Study-related adverse events The adverse events most commonly reported in 5% of adult patients treated with Victoza 1.8 mg vs Januvia 100 mg, both in combination with metformin, were nausea (21.8% vs 7.8%), diarrhea (16.3% vs 9.3%), decreased appetite (8.9% vs 3.4%), vomiting (7.4% vs 4.9%), headache (6.4% vs 5.9%), nasopharyngitis (5.9% vs 3.4%), and increased lipase (5.5% vs 4.4%)
Short version: Peak Wellness is a cash-pay telehealth clinic that prescribes compounded GLP-1 medications, semaglutide and tirzepatide, for weight loss
Tesofensine lowers body weight mainly by reducing appetite, increasing satiety, and enhancing energy expenditure, making it a promising candidate for the pharmacological treatment of obesity 1-4 .
NRF2 inducers, like sulforaphane modify cysteine sensors of Keap1 and inactivate its repressor function
Parker AE (2025)
Molecular determinants of macrophage tropism and viral persistence: Importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus